Death from Prostate cancer prevented with screening
Death from Prostate cancer prevented with screening
A study reviewing the impact of yearly prostate specific antigen (PSA) tests as a component of prostate cancer screening has found that men undergoing frequent testing have a better prognosis when prostate cancer is diagnosed than those who do not. Those who had annual blood tests were found to have a less aggressive form of cancer at diagnosis and were less likely to have a recurrence after treatment. PSA readings in conjunction with digital rectal examinations (DRE) are the current preferred screening techniques for cancer of the prostate, although the screening is not highly sensitive. Also many men might have a non-aggressive form of cancer or are of an age at diagnosis that they die with the disease, not from it, and surgical intervention would reduce their quality of life rather than positively prolonging it. Prostate cancer is currently second to skin cancer in prevalence amongst American males.
Source: summary of medical news story as reported by Health Day News
Votes:19
Comments: 0